The Covid-19 Cicada Variant Is Here. Your Immunity Probably Doesn’t Recognize It.

A Covid variant that named itself after an insect known for going underground for years before reappearing in massive, inevitable numbers has an almost poetic quality, and not in a comforting way. In November 2024, BA.3.2 was discovered in a sample from South Africa. It hardly registered for months. No rush of official statements, no alarm, and no headlines. Then it spread silently. Detections were increasing globally by September 2025. The first domestic diagnosis of it was made in January 2026 for a patient in the United States. At least 25 states, including California, Connecticut, Texas, and Vermont, had found it in wastewater samples by the end of March. The Cicada variation had surfaced.

The name was given informally, in part because the analogy felt awkward and in part because it was a joke about how long the thing had been circulating underground before anyone really noticed. The National Foundation for Infectious Diseases’ medical director, Dr. Robert H. Hopkins Jr., verified the naming logic to USA Similar to the insect, BA.3.2 went unnoticed for a considerable amount of time before making an abrupt appearance in volume today. It’s a compelling tale. Additionally, it serves as a helpful reminder that viruses do not adhere to media cycles. Long before tracking advisories were issued by public health organizations, this one was quietly working.

The sheer number of mutations that the Cicada variant carries is what makes it scientifically intriguing and what is causing virologists to express real, measured concern. The spike protein of BA.3.2, the portion of the virus that attaches itself to human cells to start infection, has between 70 and 75 genetic alterations. That’s quite a bit. To put things in perspective, the current COVID-19 vaccines were created to prime the immune system against strains of the JN.1 lineage, which has been the dominant strain in the US since early 2024. Immune systems that have been trained to identify JN.1 through vaccination or previous infection may not be able to identify BA.3.2 as quickly because it differs sufficiently from those strains. Imagine attending a reunion and hardly recognizing a classmate who has completely changed their appearance, as one immunologist put it. Eventually, you’ll figure it out. However, it takes longer, and the virus has already gained an advantage during that time.

The precise level of protection that the current vaccines provide against BA.3.2 is still unknown. Hopkins has taken care to note that although the current boosters are not as effective at preventing infection, they can still lower hospitalizations and serious illness. That subtlety is important. According to all available data, the clinical severity of the Cicada variant is not higher than that of more recent strains. It has not been connected to any unusual hospitalization spikes. The symptoms—sore throat, exhaustion, congestion, headache, and cough—seem familiar, but some patients and medical professionals have reported extremely sharp throat pain, the kind that previous variations occasionally caused and that medical professionals have dubbed “razorblade throat.” Similar to other recent Omicron descendants, gastrointestinal symptoms, such as nausea and diarrhea, have also occasionally appeared.

The spread of the problem is more urgent than its severity. By February 2026, BA.3.2 was already responsible for up to 30% of COVID infections in some Eastern European nations. For a variant that hardly showed up on tracking dashboards six months prior, that is an impressive share. In late February, the WHO added it to its list of monitoring variations. After observing a consistent rise in domestic detections, the CDC started monitoring it through routine surveillance. As of mid-February, wastewater monitoring, one of the most trustworthy early-warning systems for strain shifts, detected BA.3.2 in samples from 132 locations nationwide, identifying infections in individuals who are never formally tested. Since 2022, fewer states have submitted wastewater data to the CDC, indicating that this variant’s actual footprint is likely larger than what the current map indicates.

Speaking with public health researchers who have experienced multiple variant cycles, there is a feeling of cautious familiarity rather than alarm. Every discussion about BA.3.2 raises the question of a possible summer surge because summer has turned into a kind of recurring COVID season as people move inside to avoid the heat, ventilation decreases in some areas, and social gatherings become more concentrated. According to Northeastern University associate clinical professor Brandon Dionne, “There definitely are quite a few mutations with this one, so there’s concern that the current vaccine is not going to be a great match.” That’s not a reason to panic. While vaccine formulators determine whether an updated target is required, it provides a realistic assessment of the current situation.

The useful advice hasn’t changed, and to be honest, it probably won’t. If you fall into a higher-risk category, wash your hands, stay at home when experiencing symptoms, wear a mask in crowded or enclosed areas, and consult a clinician if you have underlying medical conditions that increase your risk of developing a serious illness. Long COVID still affects about three out of every 100 cases, even though its incidence has decreased as the virus has changed. This statistic should remain in the public’s awareness even when the worst-case headlines aren’t present to compel the reminder. People who have weakened immune systems, long-term lung conditions, or the aftereffects of past infections are observing the spread of BA.3.2 with the quiet attention that comes from having been burned in the past.

It’s difficult to ignore the fact that this kind of variation appears at a time when the nation’s desire for ongoing attention to Covid has effectively run out. The infrastructure for surveillance has diminished. There is less testing. Reporting is more inconsistent. Nevertheless, the virus continues to mutate, adapt, and identify weaknesses in the collective immunity that years of exposure and vaccination have gradually strengthened. The Cicada variant emerged without requesting permission. It simply waited, transformed into something less identifiable, and began to proliferate. It is genuinely unknown whether that results in a significant summer wave or fades as faster-moving strains outcompete it; anyone who claims otherwise is speculating.